The impact of a newly established specialized pediatric epilepsy center in Tanzania: An observational study

Miriam Aricò1, Mario Mastrangelo2, Sofia Pia Di Noia3

  • 1Division of Child and Adolescent Neurology and Psychiatry, Department of Human Neuroscience, Sapienza University of Rome, Rome, Italy; UOC Neuropsichiatria Infantile, Azienda Unità Sanitaria Locale Bologna, Italy.

Epilepsy & Behavior : E&B
|September 30, 2023
PubMed

Insights

A new pediatric epilepsy clinic in Tanzania improved diagnosis and treatment, with 76% of patients achieving seizure freedom. Enhancing access to antiseizure medications like sodium valproate is crucial for better outcomes in resource-limited settings.

Area of Science:

  • Neurology
  • Global Health
  • Pediatrics

Background:

  • Pediatric epilepsy diagnosis and management present unique challenges in resource-limited settings.
  • Establishing specialized clinics can improve diagnostic accuracy and patient care.

Purpose of the Study:

  • To evaluate the impact of a newly established pediatric epilepsy clinic in Ifakara, Tanzania.
  • To assess the spectrum of epilepsy and treatment outcomes in a resource-limited environment.

Main Methods:

  • Recruitment of patients aged 0-18 years referred to the Pediatric Epilepsy Unit.
  • Collection of demographic and clinical data using Kobo Toolbox.
  • Descriptive analysis of collected data, including EEG findings and diagnoses.

Main Results:

  • 143 pediatric patients evaluated; epilepsy confirmed in 87.
  • Focal epilepsy (57) and generalized epilepsy (24) were common diagnoses.
  • Electroencephalogram (EEG) abnormalities detected in 80.85% of recorded EEGs.
  • Hypoxic-ischemic encephalopathy was the most frequent etiology (39%).
  • Phenobarbital was the most used antiseizure medication (ASM); therapeutic changes proposed for 95 patients.
  • 76% of patients achieved complete seizure freedom at follow-up.

Conclusions:

  • The study highlights the epilepsy spectrum in pediatric patients in a resource-limited setting.
  • Improving access to essential ASMs, including sodium valproate and newer generation medications, is vital for enhancing prognostic implications.
  • Specialized clinics improve epilepsy care and outcomes in underserved regions.
Abstract